CASC9 and gastric adenocarcinoma: Interestingly, the high expression of CASC9 had a worse prognosis than the low one in LIHC while the high expression of CASC9 had a better prognosis in STAD, suggesting that CASC9 was a risk factor in LIHC and a protective factor in STAD.